Article
Antisense Oligonucleotide: Basic Concepts and Therapeutic Application in Inflammatory Bowel Disease
29 Mar 2019
Abstract excerpt
Antisense oligonucleotide (ASO) technology is a specific, rapid, and potentially high-throughput method for inhibiting gene expression. ASO refers to a short synthetic strand of deoxy-ribonucleotide analogue that hybridizes with the complementary mRNA via Watson–Crick base pairing. The resulting RNA-DNA heteroduplex leads to a reduced translation of the target transcript thus inducing a blockade in the transfer...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
